Brinker Capital’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,070
Closed -$656K 959
2019
Q3
$656K Buy
14,070
+4,961
+54% +$231K 0.02% 626
2019
Q2
$476K Sell
9,109
-2,003
-18% -$117K 0.02% 694
2019
Q1
$766K Buy
11,112
+7,543
+211% +$506K 0.03% 551
2018
Q4
$213K Sell
3,569
-4,591
-56% -$396K 0.01% 822
2018
Q3
$945K Buy
8,160
+13
+0.2% +$1.47K 0.03% 509
2018
Q2
$1.03M Sell
8,147
-482
-6% -$58.7K 0.04% 471
2018
Q1
$934K Sell
8,629
-17,690
-67% -$1.96M 0.04% 479
2017
Q4
$2.88M Sell
26,319
-4,383
-14% -$437K 0.11% 187
2017
Q3
$3.03M Sell
30,702
-2,211
-7% -$214K 0.13% 173
2017
Q2
$3.33M Buy
32,913
+1,447
+5% +$156K 0.15% 152
2017
Q1
$3.63M Buy
31,466
+5,988
+24% +$696K 0.17% 131
2016
Q4
$3.06M Buy
25,478
+19,415
+320% +$2.15M 0.17% 132
2016
Q3
$681K Buy
6,063
+841
+16% +$96.9K 0.07% 127
2016
Q2
$647K Buy
5,222
+678
+15% +$81.8K 0.06% 131
2016
Q1
$510K Buy
+4,544
New +$472K 0.04% 194

Other funds holding CLB

Brinker Capital's CLB Position: Q4 2019 in Review

Brinker Capital sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 14,070 shares — an estimated $656K sold.

Brinker Capital first reported a position in CLB in Q1 2016 and held it in 15 quarters. The position peaked at $3.63M in Q1 2017. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Brinker Capital reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • Brinker Capital sold 14,070 Core Laboratories shares in Q4 2019, an estimated $656K.
  • Brinker Capital first reported a position in Core Laboratories in Q1 2016 and held it in 15 quarters.
  • Brinker Capital's Core Laboratories position peaked at $3.63M in Q1 2017.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Brinker Capital's 13F filing for Q4 2019, filed 18 Feb 2020.